Yao Wei, Li Kai, Xiao Xianmin, Gao Jiechun, Dong Kuiran, Xiao Xianmin, Lv Zhibao
Department of Surgery, Children's Hospital of Fudan University, Shanghai, P.R. China.
J Invest Surg. 2012 Jun;25(3):181-5. doi: 10.3109/08941939.2011.615893.
Wilms' tumor (WT), or nephroblastoma, is the most common renal malignancy of childhood, and its outcome varies. We aimed to retrospectively review the clinical parameters and outcomes of WT cases treated at our medical center to identify factors associated with its prognosis.
We retrospectively reviewed WT patients who had undergone surgery and other therapy in our hospital from May 1998 to May 2008. Demographic features, mode of presentation, stage of tumor, histopathologic results, and survival rates were evaluated.
Our study included 67 children with WT; 38 were males and 29 were females. The mean age at onset was 39 months. Eighteen cases were diagnosed as Stage I, 23 as Stage II, 20 as Stage III, and 6 as Stage IV. Nephroureterectomy was the initial treatment in 57 children. There were 46 (68.7%) cases of favorable histology and 21 (31.3%) cases of unfavorable (anaplastic) histology. The rates of four-year event-free survival and overall survival were 78.3% and 81%, respectively. The four-year overall survival rate for cases of favorable histology (85.8%) was higher than for those with unfavorable histology (71.4%; p =.028).
The outcomes of WT patients in our institution were little poorer than for those of the third National Wilms Tumor Study. Advanced clinical stage at presentation, unfavorable histology, tumor rupture, relapse, delay of radiotherapy due to ignorance, and premature ending of treatment were the important factors that impacted on the outcome of WT.
肾母细胞瘤(WT),即肾胚胎瘤,是儿童期最常见的肾脏恶性肿瘤,其预后各不相同。我们旨在回顾性分析在我院接受治疗的WT病例的临床参数和预后,以确定与预后相关的因素。
我们回顾性分析了1998年5月至2008年5月在我院接受手术及其他治疗的WT患者。评估了患者的人口统计学特征、临床表现方式、肿瘤分期、组织病理学结果及生存率。
我们的研究纳入了67例WT患儿;其中38例为男性,29例为女性。发病时的平均年龄为39个月。18例被诊断为I期,23例为II期,20例为III期,6例为IV期。57例患儿的初始治疗为肾输尿管切除术。组织学类型良好的有46例(68.7%),组织学类型不良(间变)的有21例(31.3%)。四年无事件生存率和总生存率分别为78.3%和81%。组织学类型良好的病例的四年总生存率(85.8%)高于组织学类型不良的病例(71.4%;p = 0.028)。
我院WT患者的预后略逊于第三次全国肾母细胞瘤研究的患者。就诊时临床分期较晚、组织学类型不良、肿瘤破裂、复发、因疏忽导致放疗延迟以及治疗过早结束是影响WT预后的重要因素。